AI/MLMay 2026
What 'Predetermined Change Control' Actually Means for Your AI Model
A practical read on how the FDA's PCCP framework changes the way adaptive AI/ML diagnostics get authorized — and maintained over time.
A practical read on how the FDA's PCCP framework changes the way adaptive AI/ML diagnostics get authorized — and maintained over time.
Why the De Novo pathway deserves a seat at the table from day one, not just when 510(k) options run out.
The case for hiring regulatory leadership earlier than instinct says you should — and what that role should own first.
The questions I ask before I ever look at a sensitivity and specificity table.
Reframing regulatory affairs as a function that unblocks good work, not one that exists to say no.
What an FDA reviewer is actually looking for in your §524B submission, and where most teams under-build.